Literature DB >> 27184108

The protonation state of histidine 111 regulates the aggregation of the evolutionary most conserved region of the human prion protein.

Luis Fonseca-Ornelas1, Markus Zweckstetter1,2,3.   

Abstract

In a group of neurodegenerative diseases, collectively termed transmissible spongiform encephalopathies, the prion protein aggregates into β-sheet rich amyloid-like deposits. Because amyloid structure has been connected to different prion strains and cellular toxicity, it is important to obtain insight into the structural properties of prion fibrils. Using a combination of solution NMR spectroscopy, thioflavin-T fluorescence and electron microscopy we here show that within amyloid fibrils of a peptide containing residues 108-143 of the human prion protein [humPrP (108-143)]-the evolutionary most conserved part of the prion protein - residue H111 and S135 are in close spatial proximity and their interaction is critical for fibrillization. We further show that residues H111 and H140 share the same microenvironment in the unfolded, monomeric state of the peptide, but not in the fibrillar form. While protonation of H140 has little influence on fibrillization of humPrP (108-143), a positive charge at position 111 blocks the conformational change, which is necessary for amyloid formation of humPrP (108-143). Our study thus highlights the importance of protonation of histidine residues for protein aggregation and suggests point mutations to probe the structure of infectious prion particles.
© 2016 The Protein Society.

Entities:  

Keywords:  NMR spectroscopy; amyloid; misfolding; prion protein

Mesh:

Substances:

Year:  2016        PMID: 27184108      PMCID: PMC4972213          DOI: 10.1002/pro.2947

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  24 in total

1.  Assessing the acid-base and conformational properties of histidine residues in human prion protein (125-228) by means of pK(a) calculations and molecular dynamics simulations.

Authors:  Emma Langella; Roberto Improta; Orlando Crescenzi; Vincenzo Barone
Journal:  Proteins       Date:  2006-07-01

2.  High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes.

Authors:  U Finckh; T Müller-Thomsen; U Mann; C Eggers; J Marksteiner; W Meins; G Binetti; A Alberici; C Hock; R M Nitsch; A Gal
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

3.  Consistent blind protein structure generation from NMR chemical shift data.

Authors:  Yang Shen; Oliver Lange; Frank Delaglio; Paolo Rossi; James M Aramini; Gaohua Liu; Alexander Eletsky; Yibing Wu; Kiran K Singarapu; Alexander Lemak; Alexandr Ignatchenko; Cheryl H Arrowsmith; Thomas Szyperski; Gaetano T Montelione; David Baker; Ad Bax
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-07       Impact factor: 11.205

4.  Molecular conformation and dynamics of the Y145Stop variant of human prion protein in amyloid fibrils.

Authors:  Jonathan J Helmus; Krystyna Surewicz; Philippe S Nadaud; Witold K Surewicz; Christopher P Jaroniec
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-24       Impact factor: 11.205

Review 5.  Molecular dynamics as an approach to study prion protein misfolding and the effect of pathogenic mutations.

Authors:  Marc W van der Kamp; Valerie Daggett
Journal:  Top Curr Chem       Date:  2011

6.  Determination of amyloid core structure using chemical shifts.

Authors:  Lukasz Skora; Markus Zweckstetter
Journal:  Protein Sci       Date:  2012-10-26       Impact factor: 6.725

Review 7.  Protein aggregates in Huntington's disease.

Authors:  Montserrat Arrasate; Steven Finkbeiner
Journal:  Exp Neurol       Date:  2011-12-19       Impact factor: 5.330

8.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

9.  Burial of the polymorphic residue 129 in amyloid fibrils of prion stop mutants.

Authors:  Lukasz Skora; Luis Fonseca-Ornelas; Romina V Hofele; Dietmar Riedel; Karin Giller; Jens Watzlawik; Walter J Schulz-Schaeffer; Henning Urlaub; Stefan Becker; Markus Zweckstetter
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

10.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.